, Volume 13, Issue 10–11, pp 618–644

Femmes à risque

  • M. Cohen
  • J. Jacquemier
  • C. Maestro
  • P. Pujol
  • E. Saada
Recommandations / Guidelines


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abdel-Fatah TM, Powe DG, Hodi Z, et al. (2007) High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 31: 417–426PubMedGoogle Scholar
  2. 2.
    Ali-Fehmi R, Carolin K, Wallis T, Visscher DW (2003) Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 34: 234–239PubMedGoogle Scholar
  3. 3.
    Allemand H, Seradour B, Weill A, Ricordeau P (2008) Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 95: 11–15PubMedGoogle Scholar
  4. 4.
    Alm El-Din MA, Hughes KS, Finkelstein DM, et al. (2009) Breast cancer after treatment of Hodgkin’s lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys 73(1): 69–74PubMedGoogle Scholar
  5. 5.
    Anderson BO, Calhoun KE, Rosen EL (2006) Evolving concepts in the management of lobular neoplasia. J Natl Compr Canc Netw 4: 511–522PubMedGoogle Scholar
  6. 6.
    Aroner SA, Collins LC, Schnitt SJ, et al. (2010) Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res 12: R61PubMedGoogle Scholar
  7. 7.
    Arpino G, Allred DC, Mohsin SK, et al. (2004) Lobular neoplasia on core-needle biopsy — clinical significance. Cancer 101: 242–250PubMedGoogle Scholar
  8. 8.
    Arpino G, Laucirica R, Elledge RM (2005) Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143: 446–457PubMedGoogle Scholar
  9. 9.
    Barlow WE (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98(17): 1204–1214PubMedGoogle Scholar
  10. 10.
    Barrett-Connor E, Mosca L, Collins P, et al. (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355: 125–137PubMedGoogle Scholar
  11. 11.
    Bauer VP, Ditkoff BA, Schnabel F, et al. (2003) The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 9: 4–9PubMedGoogle Scholar
  12. 12.
    Berg WA, Blume JD, Cormack JB, et al. (2008) ACRIN 6666 Investigators. Combined screening withultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18): 2151–2163PubMedGoogle Scholar
  13. 13.
    Bijker N, Peterse JL, Duchateau L, et al. (2001) Risk factors for recurrence and metastasis after breastconserving therapy for ductal carcinoma in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19: 2263–2271PubMedGoogle Scholar
  14. 14.
    Bijker N, Rutgers EJ, Peterse JL, et al. (2001) Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 27: 135–40PubMedGoogle Scholar
  15. 15.
    Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440: 134–138PubMedGoogle Scholar
  16. 16.
    Bratthauer GL, Tavassoli FA (2004) Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 444: 340–344PubMedGoogle Scholar
  17. 17.
    Brem RF, Behrndt VS, Sanow L, Gatewood OM (1999) Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 172: 1405–1407PubMedGoogle Scholar
  18. 18.
    Brogi E, Oyama T, Koerner FC (2001) Atypical cystic lobules in patients with lobular neoplasia. Int J Surg Pathol 9: 201–206PubMedGoogle Scholar
  19. 19.
    Brogi E, Tan LK(2002) Findings at excisional biopsy (EBX) performed after identification of columnar cell change (CCC) of ductal epithelium in breast core biopsy (CBX). Mod Pathol 15: 29A–30AGoogle Scholar
  20. 20.
    Bur ME, Zimarowski MJ, Schnitt SJ, et al. (1992) Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 69: 1174–1181PubMedGoogle Scholar
  21. 21.
    Cangiarella J, Guth A, Axelrod D, et al. (2008) Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy? A report of 38 cases and review of the literature. Arch Pathol Lab Med 132: 979–983PubMedGoogle Scholar
  22. 22.
    Carney PA, Miglioretti DL, Yankaskas BC, et al. (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138(3): 168–175 [Erratum in: Ann Intern Med 2003 May 6; 138(9): 771]PubMedGoogle Scholar
  23. 23.
    Chuba PJ, Hamre MR, Yap J, et al. (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma in situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23: 5534–5541PubMedGoogle Scholar
  24. 24.
    Colditz GA, Rosner BA, Speizer FE (1996) Risk factors for breast cancer according to family history of breast cancer. For the Nurses’ Health Study Research Group. J Natl Cancer Inst 88: 365–371PubMedGoogle Scholar
  25. 25.
    Colin C, Prince V, Valette PJ (2010) Can mammographic assessments lead to consider density as a risk factor for breast cancer? Eur J Radiology 4465Google Scholar
  26. 26.
    Collins LC, Achacoso NA, Nekhlyudov L, et al. (2007) Clinical and pathologi features of ductal carcinoma in situ associated with presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol 20: 1149–1155PubMedGoogle Scholar
  27. 27.
    Collins LC, Baer HJ, Tamimi RM, et al. (2007) Magnitude and laterality of breast cancer risk according to histology type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109: 180–187PubMedGoogle Scholar
  28. 28.
    CRC (1988) Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party. Br J Cancer 57: 604–607Google Scholar
  29. 29.
    Cummings SR, Eckert S, Krueger KA, et al. (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA 281: 2189–2197PubMedGoogle Scholar
  30. 30.
    Cutuli B, Cottu PH, Guastalla JP, et al. (2006) A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1,159 patients. Breast Cancer Res Treat 95: 55–64PubMedGoogle Scholar
  31. 31.
    Cuzick J, Forbes J, Edwards R, et al. (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet 360: 817–824PubMedGoogle Scholar
  32. 32.
    Cuzick J, Powles T, Veronesi U, et al. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361: 296–300PubMedGoogle Scholar
  33. 33.
    Dabbs DJ, Carter G, Fudge M, et al. (2006) Molecular alterations in columnar cell lesions of the breast. Mod Pathol 19: 344–349PubMedGoogle Scholar
  34. 34.
    Darling ML, Smith DN, Lester SC, et al. (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 175: 1341–1346PubMedGoogle Scholar
  35. 35.
    David N, Labbe-Devilliers C, Moreau D, et al. (2006) Lésions de métaplasie cylindrique atypique (MCA) diagnostiquées par macrobiopsies assistées par aspiration: opportunité d’une exérèse chirurgicale ? J Radiol 87: 1671–1677PubMedGoogle Scholar
  36. 36.
    De Mascarel I, Mac Grogan G (2007) Prise en charge des atypies épithéliales du sein. Ann Pathol 27: 182–194PubMedGoogle Scholar
  37. 37.
    De Mascarel I, Mac Grogan G, Mathoulin-Pelissier S, et al. (2007) Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch 451: 1–10PubMedGoogle Scholar
  38. 38.
    Degnim AC, Visscher DW, Berman HK, et al. (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25: 2671–2677PubMedGoogle Scholar
  39. 39.
    Doren E, Hulvat M, Norton J, et al. (2008) Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg 195: 358–361 [361–2 discussion]PubMedGoogle Scholar
  40. 40.
    Douglas-Jones AG, Denson JL, Cox AC, et al. (2006) Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy. J Clin Pathol 60(3): 295–298 [Epub 2006 May 26]PubMedGoogle Scholar
  41. 41.
    Dupont WD, Parl FF, Hartmann WH, et al. (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71: 1258–1265PubMedGoogle Scholar
  42. 42.
    Eisinger F, Bressac B, Castaigne D, et al. (2004) Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 91(3): 219–237 [Review French]PubMedGoogle Scholar
  43. 43.
    Elston CW, Sloane JP, Amendoeira I, et al. (2000) Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer 36: 1769–1772PubMedGoogle Scholar
  44. 44.
    Ely KA, Carter BA, Jensen RA, et al. (2001) Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 25: 1017–1021PubMedGoogle Scholar
  45. 45.
    Eusebi V, Mignani S, Koerner F, Oyama T (2001) Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous. Breast Cancer 8: 283–284PubMedGoogle Scholar
  46. 46.
    Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. (2006) Lobular intraepithelial neoplasia (lobular carcinoma in situ) with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol 30: 1445–1453PubMedGoogle Scholar
  47. 47.
    Farshid G, Rush G (2004) Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer. Am J Surg Pathol 28: 1626–1631PubMedGoogle Scholar
  48. 48.
    Fasching PA, Bani MR, Nestle-Krämling C, et al. (2007) Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16(3): 216–224PubMedGoogle Scholar
  49. 49.
    Fasih T, Jain M, Shrimankar J, et al. (2005) All radial scars/complex sclerosing lesions seen on breast screening mammograms should be excised. Eur J Surg Oncol 31: 1125–1128PubMedGoogle Scholar
  50. 50.
    Fisher B, Costantino J, Redmond C, et al. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479–484PubMedGoogle Scholar
  51. 51.
    Fisher B, Costantino JP, Wickerham DL, et al. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371–1388PubMedGoogle Scholar
  52. 52.
    Fisher B, Costantino JP, Wickerham DL, et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652–1662PubMedGoogle Scholar
  53. 53.
    Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 122: 1053–1055Google Scholar
  54. 54.
    Foregeard C, Benchaib M, Guerin N, et al. (2008) Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg 196(3): 339–345Google Scholar
  55. 55.
    Fraser JL, Raza S, Chorny K, et al. (1998) Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22: 1521–1527PubMedGoogle Scholar
  56. 56.
    Friedenreich C, Bryant H, Alexander F, et al. (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29: 637–644PubMedGoogle Scholar
  57. 57.
    Gail MH, Brinton LA, Byar DP, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879–1886PubMedGoogle Scholar
  58. 58.
    Georgian-Smith D, Lawton TJ (2001) Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 176: 1255–1259PubMedGoogle Scholar
  59. 59.
    Ghofrani M, Tapia B, Tavassoli FA (2006) Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch 449: 609–616PubMedGoogle Scholar
  60. 60.
    Greene T, Tartter PI, Smith SR, Estabrook A (2006) The significance of surgical margins for patients with atypical ductal hyperplasia. Am J Surg 192: 499–501PubMedGoogle Scholar
  61. 61.
    Guerra-Wallace MM, Christensen WN, White RL Jr (2004) A restrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg 188: 395–398PubMedGoogle Scholar
  62. 62.
    Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42: 737–769PubMedGoogle Scholar
  63. 63.
    Hartmann LC, Sellers TA, Frost MH, et al. (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353: 229–237PubMedGoogle Scholar
  64. 64.
    Hede K (2004) Rexinoids may be ready for prime time in prevention, but challenges remain. J Natl Cancer Inst 96: 1807–1808PubMedGoogle Scholar
  65. 65.
    Hwang H, Barke LD, Mendelson EB, Susnik B (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21(10): 1208–1216PubMedGoogle Scholar
  66. 66.
    Jacobi CE, de Bock GH, Siegerink B, van Asperen CJ (2009) Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Breast Cancer Res Treat 115(2): 381–390 [Epub 2008 May 30]PubMedGoogle Scholar
  67. 67.
    Jacobs TW, Byrne C, Colditz G, et al. (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340(6): 430–436PubMedGoogle Scholar
  68. 68.
    Jacobs TW, Connolly JL, Schnitt SJ (2002) Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 26: 1095–1110PubMedGoogle Scholar
  69. 69.
    Jacobs TW, Schnitt SJ, Tan X, Brown LF (2002) Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol 33: 29–38PubMedGoogle Scholar
  70. 70.
    Jordan VC, Lababidi MK, Langan-Fahey S (1991) Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 83: 492–496PubMedGoogle Scholar
  71. 71.
    Koerner FC, Oyama T, Maluf H (2001) Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type). Virchows Arch 439: 523–530PubMedGoogle Scholar
  72. 72.
    Kriege M, Brekelmans CT, Boetes C, et al. (2004) Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5): 427–437PubMedGoogle Scholar
  73. 73.
    Kuhl CK, Schrading S, Leutner CC, et al. (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23: 8469–8476PubMedGoogle Scholar
  74. 74.
    Kunju LP, Kleer CG (2007) Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? Hum Pathol 38: 35–41PubMedGoogle Scholar
  75. 75.
    Lakhani SR, Audretsch W, Cleton-Jensen AM, et al. (2006) The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer 42: 2205–2211PubMedGoogle Scholar
  76. 76.
    Lavoue V, Graesslin O, Classe JM, et al. (2007) Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast 16: 533–539PubMedGoogle Scholar
  77. 77.
    Leach MO, Boggis CR, Dixon AK, et al. (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365(9473): 1769–1778 [Erratum in: Lancet 2005 May 28–Jun 3; 365(9474): 1848]PubMedGoogle Scholar
  78. 78.
    Leconte I, Feger C, Galant C, et al. (2003) Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 180(6): 1675–1679PubMedGoogle Scholar
  79. 79.
    Lee CH, Dershaw DD, Kopans D, et al. (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1): 18–27PubMedGoogle Scholar
  80. 80.
    Lerwill MF (2006) The evolution of lobular neoplasia. Adv Anat Pathol 13: 157–165PubMedGoogle Scholar
  81. 81.
    Lerwill MF (2008) Flat epithelial atypia of the breast. Arch Pathol Lab Med 132: 615–621PubMedGoogle Scholar
  82. 82.
    Lewis JT, Hartmann LC, Vierkant RA, et al. (2006) An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 30: 665–672PubMedGoogle Scholar
  83. 83.
    Li CI, Malone KE, Saltzman BS, Daling JR (2006) Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 106: 2104–2112PubMedGoogle Scholar
  84. 84.
    Liberman L, Holland AE, Marjan D, et al. (2007) Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 188: 684–690PubMedGoogle Scholar
  85. 85.
    Liby K, Rendi M, Suh N, et al. (2006) The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer. Clin Cancer Res 12: 5902–5909PubMedGoogle Scholar
  86. 86.
    Londero V, Zuiani C, Linda A, et al. (2008) Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast 17(6): 623–630PubMedGoogle Scholar
  87. 87.
    Lopez-Medina A, Cintora E, Mugica B, et al. (2006) Radial scars diagnosed at stereotactic core-needle biopsy: surgical biopsy findings. Eur Radiol 16(8): 1803–1810PubMedGoogle Scholar
  88. 88.
    Mac Grogan G, Tavassoli FA (2003) Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch 443: 609–617Google Scholar
  89. 89.
    Mahoney MC, Robinson-Smith TM, Shaughnessy EA (2006) Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol 187: 949–954PubMedGoogle Scholar
  90. 90.
    Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18(7): 1307–1318PubMedGoogle Scholar
  91. 91.
    Martino S, Cauley JA, Barrett-Connor E, et al. (2004) Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 96: 1751–1761PubMedGoogle Scholar
  92. 92.
    McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6): 1159–1169PubMedGoogle Scholar
  93. 93.
    Moinfar F, Man YG, Bratthauer GL, et al. (2000) Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (“clinging ductal carcinoma in situ”): a simulator of normal mammary epithelium. Cancer 88: 2072–2081PubMedGoogle Scholar
  94. 94.
    Mokbel K, Price RK, Carpenter R (1999) Radial scars and breast cancer. N Engl J Med 341: 210PubMedGoogle Scholar
  95. 95.
    Mokbel K, Price RK, Mostafa A, et al. (1999) Radial scar and carcinoma of the breast: microscopic findings in 32 cases. Breast 8: 339–342PubMedGoogle Scholar
  96. 96.
    Morris EA, Liberman L, Ballon DJ, et al. (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181(3): 619–626PubMedGoogle Scholar
  97. 97.
    Mouridsen HT, Rose C, Overgaard M, et al. (1988) Adjuvant treatment of postmenopausal patients with high-risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C. Acta Oncol 27: 699–705PubMedGoogle Scholar
  98. 98.
    MRC (1987) Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet 2: 171–175Google Scholar
  99. 99.
    National Comprehensive Cancer Network (2009) National clinical practice guidelines in oncology: breast cancer screening and diagnosis. Version 1.2010. Published mars 11, www.nccn.org
  100. 100.
    Ohuchi N, Abe R, Takahashi T, Tezuka F (1984) Origin and extension of intraductal papillomas of the breast: a three-dimensional reconstruction study. Breast Cancer Res Treat 4(2): 117–128PubMedGoogle Scholar
  101. 101.
    O’Malley FP, Mohsin SK, Badve S, et al. (2006) Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol 19: 172–179PubMedGoogle Scholar
  102. 102.
    Page DL, Dupont WD (1990) Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326–1335PubMedGoogle Scholar
  103. 103.
    Page DL, Dupont WD, Jensen RA (1996) Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 5: 29–32PubMedGoogle Scholar
  104. 104.
    Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55: 2698–2708PubMedGoogle Scholar
  105. 105.
    Page DL, Kidd Jr TE, Dupont WD, et al. (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22: 1232–1239PubMedGoogle Scholar
  106. 106.
    Page DL, Salhany KE, Jensen RA, Dupont WD (1996) Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78(2): 258–266PubMedGoogle Scholar
  107. 107.
    Page DL, Schuyler PA, Dupont WD, et al. (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361: 125–129PubMedGoogle Scholar
  108. 108.
    Patterson JA, Scott M, Anderson N, Kirk SJ (2004) Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 30(10): 1065–1068PubMedGoogle Scholar
  109. 109.
    Pauw AD, Stoppa-Lyonnet D, Andrieu N (2009) Asselain estimation of individual breast cancer risk: relevance and limits of risk estimation models B. Bull Cancer 96(10): 979–988 [French]PubMedGoogle Scholar
  110. 110.
    Pisano ED, Hendrick RE, Yaffe MJ, et al. (2008) DMIST Investigators Group. Diagnostic accuracy of digital vs film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246: 376–383PubMedGoogle Scholar
  111. 111.
    Plantade R, Hammou JC, Fighiera M, et al. (2004) Underestimation of breast carcinoma with 11-gauge stereotactically guided directional vacuum-assisted biopsy. J Radiol 85: 391–401.PubMedGoogle Scholar
  112. 112.
    Poller DN, Snead DR, Roberts EC, et al. (1993) Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. Br J Cancer 68: 156–161PubMedGoogle Scholar
  113. 113.
    Port ER, Park A, Borgen PI, et al. (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14(3): 1051–1057PubMedGoogle Scholar
  114. 114.
    Powles TJ, Ashley S, Tidy A, et al. (2007) Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99: 283–290PubMedGoogle Scholar
  115. 115.
    Powles TJ, Jones AL, Ashley SE, et al. (1994) The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 31: 73–82PubMedGoogle Scholar
  116. 116.
    Rao A, Parker S, Ratzer E, et al. (2002) Atypical ductal hyperplasia of the breast diagnosed by 11-gauge directional vacuum-assisted biopsy. Am J Surg 184: 534–537 [537 discussion]PubMedGoogle Scholar
  117. 117.
    Recommandations professionnelles (2009) Cancer du sein in situ. Octobre; www.e-cancer.fr
  118. 118.
    Renshaw AA, Derhagopian RP, Martinez P, Gould EW (2006) Lobular neoplasia in breast core needle biopsy specimens is associated with a low-risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol 126: 310–313PubMedGoogle Scholar
  119. 119.
    Reynolds HE, Poon CM, Goulet RJ (1998) Biopsy of breast microcalcifications using an 11-gauge directional vacuum-assisted device. AJR Am J Roentgenol 171: 611–613PubMedGoogle Scholar
  120. 120.
    Rutqvist LE, Cedermark B, Glas U, et al. (1991) Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 83: 1299–1306PubMedGoogle Scholar
  121. 121.
    Sanders ME, Page DL, Simpson JF, et al. (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106: 1453–1461PubMedGoogle Scholar
  122. 122.
    Saslow D, Boetes C, Burke W, et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2): 75–89 [Erratum in: CA Cancer J Clin 2007 May–Jun; 57(3): 185]PubMedGoogle Scholar
  123. 123.
    Schnitt SJ (2003) The diagnosis and management of pre-invasive breast disease: flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res 5: 263–268PubMedGoogle Scholar
  124. 124.
    Schnitt SJ, Vincent-Salomon A (2003) Columnar cell lesions of the breast. Adv Anat Pathol 10: 113–124PubMedGoogle Scholar
  125. 125.
    Shaaban AM, Sloane JP, West CR, et al. (2002) Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 26: 421–430PubMedGoogle Scholar
  126. 126.
    Simpson PT, Gale T, Reis-Filho JS, et al. (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29:734–746PubMedGoogle Scholar
  127. 127.
    Sneige N, Lim SC, Whitman GJ, et al. (2003) Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 119: 248–253PubMedGoogle Scholar
  128. 128.
    Sneige N, Wang J, Baker BA, et al. (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15: 1044–1050PubMedGoogle Scholar
  129. 129.
    Sohn V, Arthurs Z, Herbert G, et al. (2007) Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted vs the 14-gauge core biopsy needle. Ann Surg Oncol 14: 2497–2501PubMedGoogle Scholar
  130. 130.
    Taffurelli M, Santini D, Martinelli G, et al. (1991) Juvenile papillomatosis of the breast. A multidisciplinary study. Pathol Annu 26(Pt 1): 25–35Google Scholar
  131. 131.
    Tavassoli F, Millis R, Boecker W, Lakhani S (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs, 60–76Google Scholar
  132. 132.
    Tavassoli FA (2000) Ductal intraepithelial neoplasia (IDH, AIDH and DCIS). Breast Cancer 7: 315–320PubMedGoogle Scholar
  133. 133.
    Tavassoli FA (2001) Ductal intraepithelial neoplasia of the breast. Virchows Arch 438: 221–227PubMedGoogle Scholar
  134. 134.
    Tsao AS, Kim ES, Hong WK (2004) Chemoprevention of cancer. CA Cancer J Clin 54: 150–180PubMedGoogle Scholar
  135. 135.
    Vachon CM, van Gils CH, Sellers TA, et al. (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9(6): 217 [Review]PubMedGoogle Scholar
  136. 136.
    Van de Vijver MJ, Peterse H (2003) The diagnosis and management of pre-invasive breast disease: pathological diagnosis-problems with existing classifications. Breast Cancer Res 5: 269PubMedGoogle Scholar
  137. 137.
    Veronesi U, Maisonneuve P, Rotmensz N, et al. (2007) Tamoxifen for the prevention of breast cancer: late results of the Italian randomized tamoxifen prevention trial among women with hysterectomy. J Natl Cancer Inst 99: 727–737PubMedGoogle Scholar
  138. 138.
    Veronesi U, Maisonneuve P, Sacchini V, et al. (2002) Tamoxifen for breast cancer among hysterectomised women. Lancet 359: 1122–1124PubMedGoogle Scholar
  139. 139.
    Vogel VG (2004) Atypia in the assessment of breast cancer risk: implications for management. Diagn Cytopathol 30: 151–157PubMedGoogle Scholar
  140. 140.
    Vogel VG, Costantino JP, Wickerham DL, et al. (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295: 2727–2741PubMedGoogle Scholar
  141. 141.
    Wang J, Costantino JP, Tan-Chiu E, et al. (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96: 616–620PubMedGoogle Scholar
  142. 142.
    Warner E, Hill K, Causer P, et al. (2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol [in press]Google Scholar
  143. 143.
    Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45: 1–8PubMedGoogle Scholar
  144. 144.
    Webb PM, Byrne C, Schnitt SJ, et al. (2002) Family history of breast cancer, age and benign breast disease. Int J Cancer 100: 375–378PubMedGoogle Scholar
  145. 145.
    Winchester DJ, Bernstein JR, Jeske JM, et al. (2003) Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 138: 619–622 [622–3 discussion]PubMedGoogle Scholar
  146. 146.
    Yeh IT, Dimitrov D, Otto P, et al. (2003) Pathologic review of atypical hyperplasia identified by image guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 127: 49–54PubMedGoogle Scholar

Références électroniques

  1. 147.
  2. 148.
  3. 149.
  4. 150.
    [D] NCCN update 2010 (http://www.nccn.org)
  5. 151.
    [E] NICE clinical guideline 41 update october 2006 (http://www.nice.org.uk/guidance)

Copyright information

© Springer Verlag France 2011

Authors and Affiliations

  • M. Cohen
  • J. Jacquemier
  • C. Maestro
  • P. Pujol
  • E. Saada

There are no affiliations available

Personalised recommendations